Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial

This prospective, multicenter, phase II study investigated the use of four cycles of bortezomib-dexamethasone induction treatment, followed by high-dose melphalan and autologous stem cell transplantation (SCT) in patients with newly diagnosed light chain amyloidosis. The aim of the study was to impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnema, Monique C., Nasserinejad, Kazem, Hazenberg, Bouke, Hegenbart, Ute, Vlummens, Philip, Ypma, Paula F., Kröger, Nicolaus, Wu, Ka Lung, Kersten, Marie Jose, Schaafsma, M. Ron, Croockewit, Sandra, de Waal, Esther, Zweegman, Sonja, Tick, Lidwien, Broijl, Annemieke, Koene, Harry, Bos, Gerard, Sonneveld, Pieter, Schönland, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821610/
https://www.ncbi.nlm.nih.gov/pubmed/30923094
http://dx.doi.org/10.3324/haematol.2018.213900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821610/
https://www.ncbi.nlm.nih.gov/pubmed/30923094
http://dx.doi.org/10.3324/haematol.2018.213900

Ejemplares similares